SMFS
JAZZ icon

Squar Milner Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Squar Milner Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-765
Closed -$76K – 462
2020
Q1 		$76K Buy
765
+153
+25% +$19.8K 0.05% 321
2019
Q4 		$91K Buy
+612
New +$83.3K 0.05% 347
2019
Q3 		– Sell
-26
Closed -$4K – 467
2019
Q2 		$4K Sell
26
-30
-54% -$4.03K ﹤0.01% 624
2019
Q1 		$8K Buy
56
+30
+115% +$3.91K 0.01% 570
2018
Q4 		$3K Sell
26
-26
-50% -$3.86K ﹤0.01% 650
2018
Q3 		$9K Hold
52
– – 0.01% 520
2018
Q2 		$9K Buy
+52
New +$8.5K 0.01% 609

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squar Milner Financial Services's JAZZ Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 765 shares — an estimated $76K sold.

Squar Milner Financial Services first reported a position in JAZZ in Q2 2018 and held it in 7 quarters. The position peaked at $91K in Q4 2019. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Squar Milner Financial Services reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 765 Jazz Pharmaceuticals shares in Q2 2020, an estimated $76K.
  • Squar Milner Financial Services first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • Squar Milner Financial Services's Jazz Pharmaceuticals position peaked at $91K in Q4 2019.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.